Advances in the price performance of DNA sequencing (currently improving by about 8X per year) are making more extensive analysis of the genome (whole exome and even whole genome sequencing) and even exploration of other omes (such as the microbiome and its relation to disease) economically feasible. Anne will discuss the potential for expanding consumer DNA testing in new directions and partnering with the research community to interpret what this plethora of new data means.

Anne Wojcicki cofounded 23andMe with Linda Avey in 2007 to provide a platform to help individuals understand their own genetic information using recent advances in DNA analysis technologies and web-based interactive tools. In 2008, Time magazine named the company's saliva-based DNA-testing service "Invention of the Year". The company now has over 100,000 subscribers and is partnering with research groups to try to better interpret the relationship between genetic markers and physical traits and susceptibility to disease.